Ψ-DODFMO, also known as 4-difluoromethoxy-2,6-dimethoxyamphetamine, is a psychedelic drug of the phenethylamine, amphetamine, and ψ-phenethylamine families. It is the amphetamine (α-methyl) analogue of ψ-2C-DFMO and is also structurally related to other psychedelics like difluoromescaline (DFM) and 2C-T-35 (2C-T-DFM). The drug has been found to be active at a dose of 5 mg plus 5 mg (or 10 mg total) orally, with moderately intense effects and a relatively long duration of around 20 hours. Ψ-DODFMO was first described in the scientific literature by Daniel Trachsel in 2012. It is a controlled substance in Canada under phenethylamine blanket-ban language.
See also ψ-Phenethylamine Ψ-2C-DFMO Difluoromescaline (DFM) 2C-T-35 (2C-T-DFM)
References
External links ψ-DODFMO - Isomer Design


